In a six-month, randomized, double-blind study at 14 centers, auranofin (3 mg twice daily)
was compared with placebo in the treatment of patients with classic or definite rheumatoid …

The tumor necrosis factor (TNF) antagonists are parenterally administered biologic
response modifiers indicated for the management of rheumatoid arthritis. Although infliximab, …

Current techniques do not provide a reproducible, reliable, or valid basis for assessing
clinical skills. The need for large-scale direct observation and standardized assessment …

Tumor necrosis factor (TNF) antagonists have dramatically improved the outcomes of rheumatoid
arthritis (RA). Three agents currently available in the USA – infliximab, etanercept, and …

We report two cases of polyarteritis and one of hypersensitivity angiitis diagnosed by temporal
artery biopsy. Autopsies showed no evidence of giant cell arteritis. A review of the English …

In a randomized, open-label, controlled, multicenter, 12-week study, the efficacy and safety
of nabumetone (1,000–2,000 mg/day) versus diclofenac (100–200 mg/day), naproxen (500–…

Background Elderly patients have an elevated risk for developing gastrointestinal complications
with chronic use of nonsteroidal anti-inflammatory drugs. Study This was a randomized, …

Objective. Evaluate enthesitis, physical function, and health-related quality of life (HRQOL)
among patients with psoriatic arthritis (PsA) who are naive to anti–tumor necrosis factor …

A patient with rheumatoid arthritis who developed multiple mononeuropathies multiplex was
shown to have vasculitis in nerve biopsy, but no evidence of inflammatory muscle disease …

Two patients with Cogan's syndrome had acute bilateral hearing loss and vestibular dysfunction.
Interstitial keratitis was discovered by slit-lamp examination. Both cases responded to …